Home/Filings/8-K/0001663577-26-000020
8-K//Current report

Medinotec Inc. 8-K

Accession 0001663577-26-000020

$MDNCCIK 0001931055operating

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 12:09 PM ET

Size

193.6 KB

Accession

0001663577-26-000020

Research Summary

AI-generated summary of this filing

Updated

Medinotec Inc. Reports 2025 Annual Meeting — Directors Re-elected Unanimously

What Happened Medinotec Inc. (MDNC) filed an 8-K reporting the results of its 2025 Annual Meeting held on January 20, 2026. Shareholders re-elected five directors — Gregory Vizirgianakis, Pieter van Niekerk, Stavros G. Vizirgianakis, Joseph P. Dwyer, and Athanasios Spirakis — each receiving 9,955,835 votes FOR, with 0 votes against and 0 abstentions. Shareholders also ratified Mercurius & Associates LLP as Medinotec’s independent registered public accounting firm for fiscal 2026 by the same vote totals.

Key Details

  • Annual meeting date: January 20, 2026 (results reported on Form 8-K, Item 5.07).
  • Director election: Five directors elected to one-year terms expiring at the 2026 Annual Meeting.
  • Vote totals for each director: 9,955,835 FOR, 0 AGAINST, 0 ABSTAIN.
  • Auditor ratification: Mercurius & Associates LLP ratified as independent registered public accounting firm for fiscal 2026 (9,955,835 FOR, 0 AGAINST, 0 ABSTAIN).

Why It Matters These results confirm continuity of Medinotec’s board and its choice of auditor, which affects corporate oversight and the company’s financial reporting process. Unanimous vote totals indicate clear shareholder approval of the board slate and the auditor appointment, removing near-term uncertainty about governance and external audit arrangements. Investors tracking board composition or audit oversight can view these outcomes as maintenance of the company’s current governance structure.